Log in to save to my catalogue

Clitocine Reversal of P-Glycoprotein Associated Multi-Drug Resistance through Down-Regulation of Tra...

Clitocine Reversal of P-Glycoprotein Associated Multi-Drug Resistance through Down-Regulation of Tra...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A498259065

Clitocine Reversal of P-Glycoprotein Associated Multi-Drug Resistance through Down-Regulation of Transcription Factor NF-[kappa]B in R-HepG2 Cell Line

About this item

Full title

Clitocine Reversal of P-Glycoprotein Associated Multi-Drug Resistance through Down-Regulation of Transcription Factor NF-[kappa]B in R-HepG2 Cell Line

Publisher

Public Library of Science

Journal title

PloS one, 2012-08, Vol.7 (8), p.e40720

Language

English

Formats

Publication information

Publisher

Public Library of Science

More information

Scope and Contents

Contents

Multidrug resistance(MDR)is one of the major reasons for failure in cancer chemotherapy and its suppression may increase the efficacy of therapy. The human multidrug resistance 1 (MDR1) gene encodes the plasma membrane P-glycoprotein (P-gp) that pumps various anti-cancer agents out of the cancer cell. R-HepG2 and MES-SA/Dx5 cells are doxorubicin in...

Alternative Titles

Full title

Clitocine Reversal of P-Glycoprotein Associated Multi-Drug Resistance through Down-Regulation of Transcription Factor NF-[kappa]B in R-HepG2 Cell Line

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A498259065

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A498259065

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0040720

How to access this item